• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.29% Nasdaq Up 6.19%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    10.04 Down 0.10(0.99%) Jul 22, 4:00PM EDT
    |After Hours : 10.04 0.00 (0.00%) Jul 22, 5:01PM EDT
    Prev Close:10.14
    Open:10.20
    Bid:8.93 x 2000
    Ask:10.65 x 100
    1y Target Est:24.50
    Beta:2.37759
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:9.84 - 10.22
    52wk Range:8.27 - 23.35
    Volume:136,721
    Avg Vol (3m):357,538
    Market Cap:574.52M
    P/E (ttm):N/A
    EPS (ttm):-2.09
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 0.99%574.52M
    GSKUp 0.64%106.58B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):273.56
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-2.25
    Quarterly EPS Est (Jun-16) :-0.52
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. The company’s proprietary product platform creates small molecule inhibitors of enzymes known as histone methyltransfe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback